Bio Protocol 백서

Bio Protocol

원문

bitpro가 원문에서 글자만 모은 내용이에요. 표·그림·수식은 빠지거나 깨질 수 있어요. 전체 22쪽 중 1쪽

# Overview Bio is a new financial layer for funding and developing early-stage biotech. Our mission is to reshape how biotech breakthroughs are born by enabling global communities of patients, researchers and crypto users to create user-owned research networks that fund and develop new and emerging biotechnologies from day one​. At its core, Bio is designed to help scientists raise funds for their research, create value from that research, and capture and distribute that value via commercial successes. By breaking down traditional biotech barriers and introducing a permissionless framework, Bio can accelerate life-saving discoveries while making them more accessible to all. ## Get Familiar with Bio * [**Concepts**](/bio/introduction/concepts) - Learn the core concepts of the protocol. * [**DeScientists**](/bio/descientists/descientists) - Your guide to participating in the ecosystem. * [**Developers**](/bio/developers/developers) - Learn how to build on the Bio Protocol. * [**Governance**](https://gov.bio.xyz/) - Participate in our community governance process. * [**Security**](/bio/developers/audits) - Review our audits and security resources. ## Explore the Ecosystem * [**OpenLabs**](https://docs.bio.xyz/bio/~/revisions/ZynDvDTAfb1pkVCBIZuH/introduction/concepts/openlabs) - Share hypotheses, review evidence, and collaborate with human researchers and AI agents. * [**BIOS**](https://ai.bio.xyz/) - Work with an AI scientist to explore scientific literature, design drug candidates, and plan experiments. * [**Buildspace**](https://docs.bio.xyz/bio/~/revisions/ZynDvDTAfb1pkVCBIZuH/introduction/concepts/bio-protocol/build) - Prepare your research project for funding. * [**Launchpad**](https://app.bio.xyz/launchpad) - Discover and participate in new project launches. * [**Dashboard**](https://app.bio.xyz/dashboard) - Explore DeSci markets and track project performance. * [**Biofy**](https://docs.bio.xyz/bio/~/revisions/ZynDvDTAfb1pkVCBIZuH/introduction/concepts/bio-protocol/monetize) - Discover research-backed products from the Bio ecosystem. * [**BioAgents**](https://ai.bio.xyz/) - Interact with our network of AI-powered scientific agents. # Concepts Welcome to the core concepts of the bio.xyz ecosystem. This section will introduce you to the fundamental ideas that power our platform. * [**Decentralized Science**](/bio/introduction/concepts/decentralized-science): Learn about the movement to build a more open, transparent, and collaborative scientific ecosystem using web3 technology. * [**Bio Protocol**](/bio/introduction/concepts/bio-protocol): Understand the rules, mechanisms, and incentives that govern the interactions within the bio.xyz network. * [**BioDAOs**](/bio/introduction/concepts/biodaos): Discover how decentralized autonomous organizations are being used to fund, govern, and accelerate biotechnology research and development. * [**BioAgents**](/bio/introduction/concepts/bioagents): Learn about the autonomous AI entities that automate research and operations within the ecosystem. * [**IP-Tokens**](/bio/introduction/concepts/ip-tokens): Explore how intellectual property can be represented as onchain tokens, creating new models for funding and ownership in science. # Decentralized Science The Decentralized Science (DeSci) movement aims to use the Web3 stack to build public infrastructure that fairly and equitably funds, creates, reviews, credits, stores, and disseminates scientific knowledge. DeSci works off the idea that scientific knowledge should be accessible to everyone and that the process of scientific research should be transparent. DeSci is creating a more decentralized and distributed scientific research model, making it more resistant to censorship and control by central authorities. DeSci hopes to create an environment where new and unconventional ideas can flourish by decentralizing access to funding, scientific tools, and communication channels. *Note: Some of this section was borrowed from the Ethereum Decentralized Science page, of which the authors co-authored here.* ## **How DeSci Improves Science** <a href="#how-desci-improves-science" id="how-desci-improves-science"></a> <figure><img src="https://docs.bio.xyz/~gitbook/image?url=https%3A%2F%2F499247139-files.gitbook.io%2F%7E%2Ffiles%2Fv0%2Fb%2Fgitbook-x-prod.appspot.com%2Fo%2Fspaces%252F3ba2jNU6BPQUl4RXgHor%252Fuploads%252FWL3NhVDj2FE7JKp7BReQ%252FCapture-2024-05-28-102824.png%3Falt%3Dmedia%26token%3D292816b7-1b45-49ee-ad3e-d62afd79d620&#x26;width=768&#x26;dpr=4&#x26;quality=100&#x26;sign=79bc58d2&#x26;sv=2" alt=""><figcaption></figcaption></figure> ## **Use Cases** <a href="#use-cases" id="use-cases"></a> ### **Funding** <a href="#funding" id="funding"></a> The current standard model for funding science is that individuals or groups of scientists make written applications to a funding agency. A small panel of trusted individuals score the applications and then interview candidates before awarding funds to a small portion of applicants. Aside from creating bottlenecks that often leads to a pronounced time between applying for and receiving a grant, this model is known to be highly vulnerable to the biases, self-interests and politics of the review panel. Studies have shown that grant review panels do a poor job of selecting high-quality proposals as the same proposals given to different panels have wildly different outcomes. As funding has become more scarce, it has concentrated into a smaller pool of more senior researchers with more intellectually conservative projects. The effect has created a hyper-competitive funding landscape, entrenching perverse incentives and stifling innovation. Web3 has the potential to disrupt this broken funding model by experimenting with different incentive models developed by DAOs and Web3 broadly. [Retroactive public goods funding](https://medium.com/ethereum-optimism/retroactive-public-goods-funding-33c9b7d00f0c), [quadratic funding](https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2003531), [DAO governance](https://www.antler.co/blog/daos-and-web3-governance-the-promise-implications-and-challenges-ahead) and [tokenized incentive structures](https://cdixon.org/2017/05/27/crypto-tokens-a-breakthrough-in-open-network-design) are some of the Web3 tools that could revolutionize science funding. ### **Publishing** <a href="#publishing" id="publishing"></a> Science publishing is famously problematic because it is managed by publishing companies that rely upon free labor from scientists, reviewers, and editors to generate the papers but then charge exorbitant publishing fees. The public, who have already paid for the work and the publication costs through taxation, can not access that same work without paying the publisher again, unless they are affiliated with an institution (i.e. university) with an enterprise subscription. The total fees for publishing individual science papers are often five figures ($USD), undermining the whole concept of scientific knowledge as a [public good](https://www.econlib.org/library/Enc/PublicGoods.html) while generating enormous profits for a small group of publishers. Free and open-access platforms exist in the form of preprint servers, such as [ArXiv](https://arxiv.org/), [bioRxiv](https://www.biorxiv.org/), and [medRxiv](https://www.medrxiv.org/). However, these platforms lack quality control, [anti-sybil mechanisms](https://csrc.nist.gov/glossary/term/sybil_attack), and generally do not track article-level metrics, and as a result are only used to publicize work before submission to a traditional publisher. [SciHub](https://sci-hub.se/) also makes published papers free to access, but not legally, and only after the publishers have already taken their payment and wrapped the work in strict copyright legislation. This leaves a critical gap for accessible science papers and data with an embedded legitimacy mechanism and incentive model. The tools for building such a system exist in Web3. ### **Data Storage** <a href="#data-storage" id="data-storage"></a> Scientific data can be made vastly more accessible using Web3 patterns, and distributed storage enables research to survive cataclysmic events. The starting point must be a system accessible by any decentralized identity holding the proper verifiable credentials. This allows sensitive data to be securely replicated by trusted parties, enabling redundancy and censorship resistance, reproduction of results, and even the ability for multiple parties to collaborate and add new data to the dataset. Confidential computing methods like [compute-to-data](https://7wdata.be/predictive-analytics/compute-to-data-using-blockchain-to-decentralize-data-science-and-ai-with-the-ocean-protocol) provide alternative access mechanisms to raw data replication, creating Trusted Research Environments for the most sensitive data. Trusted Research Environments have been [cited by the NHS](https://medium.com/weavechain/whats-in-store-for-the-future-of-healthcare-data-b6398745fbbb) as a future-facing solution to data privacy and collaboration by creating an ecosystem where researchers can securely work with data on-site using standardized environments for sharing code and practices. Flexible Web3 data solutions support the scenarios above and provide the foundation for truly Open Science, where researchers can create public goods without access permissions or fees. Web3 public data solutions such as IPFS, Arweave and Filecoin are optimized for decentralization. dClimate, for example, provides universal access to climate and weather data, including from weather stations and predictive climate models. ### **IP Ownership and Development** <a href="#ip-ownership-and-development" id="ip-ownership-and-development"></a> Intellectual property (IP) is a big problem in traditional science: from being stuck in universities or unused in biotechs, to being notoriously hard to value. However, ownership of digital assets (such as scientific data or articles) is something Web3 does exceptionally well using [non-fungible tokens (NFTs)](https://ethereum.org/en/nft/). In the same way that NFTs can pass revenue for future transactions back to the original creator, you can establish transparent value attribution chains to reward researchers, governing bodies (like DAOs), or even the subjects whose data is collected. [IP-NFTs](https://medium.com/molecule-blog/ip-nfts-for-researchers-a-new-biomedical-funding-paradigm-91312d8d92e6) can also function as a key to a decentralized data repository of the research experiments being undertaken, and plug into NFT and [DeFi](https://ethereum.org/en/defi/) financialization (from fractionalization to lending pools and value appraisal). The fractionalization of IP-NFTs will ensure they are highly liquid and tradeable, even by individual investors. IP-NFTs also allow natively on-chain entities such as DAOs like [VitaDAO](https://www.vitadao.com/) to conduct research directly on-chain. Furthermore, new funding models centered around attention and transaction volumes can even enable us to rethink the concept of intellectual property ownership from the very ground up. ### **Replication and Reproducibility** <a href="#replication-and-reproducibility" id="replication-and-reproducibility"></a> Reproducibility and replicability are the foundations of quality scientific discovery. * Reproducible results can be achieved multiple times in a row by the same team using the same methodology. * Replicable results can be achieved by a different group using the same experimental setup. New Web3-native tools can ensure that reproducibility and replicability are the basis of discovery. We can weave quality science into the technological fabric of academia. Web3 offers the ability to create attestations for each analysis component: the raw data, the computational engine, and the application result. The beauty of consensus systems is that when a trusted network is created for maintaining these components, each network participant can be responsible for reproducing the calculation and validating each result. ### **Organizational Design** <a href="#organizational-design" id="organizational-design"></a> Decentralized science has enabled and brought about the emergence of novel organizational structures, such as biotech DAOs. The first biotech DAO, [VitaDAO](https://www.vitadao.com/), was birthed by Molecule with the goal of funding early-stage preclinical drug development in the context of longevity. VitaDAO uses Molecule's IP-NFT framework to own, license, and transact in intellectual property generated from the projects it supports. This allows the DAO to fund and later commercialize early-stage research out of academia and capture value for the large, decentralized communities of researchers and patients. The key innovation of biotech DAOs is their lack of gate-keeping and the use of technology to mediate decisions by large communities. This enables them to address a problem that has so far been unsolvable given the lack of incentive mechanisms for widespread collaboration in biotech. ### **Automation and the Rise of Agents** <a href="#automation-and-the-rise-of-agents" id="automation-and-the-rise-of-agents"></a> The rise of artificial intelligence has introduced powerful automated agents into scientific workflows, and decentralized science provides a framework for ensuring these tools are open, transparent, and community-owned. While AI-powered agents can dramatically accelerate discovery, their development is currently dominated by large technology companies. This centralization creates risks, as proprietary models can be "black boxes" with hidden biases, and their underlying business models may have incentives that conflict with open scientific inquiry. Decentralized science offers a compelling alternative by enabling agents to be built on open, permissionless infrastructure. In a DeSci ecosystem, agents can be owned and governed by DAOs, their actions can be verified on-chain, and their incentives can be aligned with the public good through token-based rewards. This fosters a more trustworthy and collaborative environment where agents act as digital colleagues to push the boundaries of knowledge. # Bio Protocol Bio Protocol is designed to make biotechnology more open, efficient and market-driven, from early-stage funding and liquidity, to milestone-based incentives and agentic automation. Users can create a new biotech project and get it bootstrapped by the community, or directly fund and support promising biotech projects at their earliest stages, democratizing an area once limited to Big Pharma and pharma VCs. **Five connected verticals** Bio’s ecosystem is organized around five verticals. Each supports a different part of developing and advancing scientific work. | Vertical | What it enables | | ------------ | ---------------------------------------------------------------------------------------------------------------------------------------- | | **Explore** | Investigate scientific questions with **BIOS** and develop ideas through public collaboration between humans and agents on **OpenLabs**. | | **Build** | Shape research into a project and prepare it for funding through **Buildspace**. | | **Fund** | Raise capital and back scientific projects through the **Bio Launchpad**. | | **Govern** | Coordinate decisions, report progress, and maintain accountability across projects and the protocol. | | **Monetize** | Bring research-backed products to market through **Biofy**. | These verticals connect early exploration with the resources needed to advance research. Projects can continue investigating questions, collaborating, and sharing results throughout their development. ### **Protocol Goals** <a href="#protocol-goals" id="protocol-goals"></a> * Selection, creation and acceleration of new projects. * Perpetual funding and liquidity for biotech projects and assets. * Standardization of project frameworks, tokenomics and data/product suites. * Generation and commercialization of scientific IP and data. ### **Core Operations** <a href="#core-operations" id="core-operations"></a> To achieve these goals, the Bio Protocol enables 5 core operations: 1. Selection 2. Funding 3. Liquidity 4. Transparency 5. Support #### **1. Selection** <a href="#selection" id="selection"></a> * BIO token holders participate in selecting which new projects join the ecosystem, enabling a bottom-up approach to funding and developing science. * Projects that are selected by the community can then be funded, added to the treasury and ultimately supported by the Bio Protocol. * As the Bio Protocol relies on high-quality projects, selection requires staking BIO tokens to participate, ensuring that those participating are long-term aligned with the network. #### **2. Funding** <a href="#funding" id="funding"></a> * If a project applicant is accepted into the network, all BIO holders with staked tokens qualify to take part in the initial sale of the project. * Through BIO, users are thus able to support groundbreaking science from day one, on equal to or better terms than VCs or other institutions. * For projects, this creates an opportunity to align a pre-established, high-value scientific community (often made up researchers or patients directly affected by the project's scientific mission) to become active stakeholders and participants in R\&D, e.g., through decentralized trials and research. {% hint style="info" %} Buy BIO on: * [Ethereum](https://app.uniswap.org/swap?chain=mainnet\&inputCurrency=NATIVE\&outputCurrency=0xcb1592591996765ec0efc1f92599a19767ee5ffa) * [Solana](https://raydium.io/swap/?inputMint=sol\&outputMint=bioJ9JTqW62MLz7UKHU69gtKhPpGi1BQhccj2kmSvUJ) * [Base](https://app.uniswap.org/swap?chain=base\&inputCurrency=NATIVE\&outputCurrency=0x226a2fa2556c48245e57cd1cba4c6c9e67077dd2) {% endhint %} #### **3. Liquidity** <a href="#liquidity" id="liquidity"></a> * Projects should focus on science, not managing liquidity. Bio Protocol alleviates this issue by managing project secondary market liquidity positions. * The protocol supports onchain liquidity using the BIO token and other token holdings in the Bio Protocol treasury. * The BIO token can be paired in liquidity pools with project tokens (e.g., VITA/BIO, HAIR/BIO), as well as with base assets (e.g., BIO/ETH) to facilitate low-cost conversions, accruing fees for the project and the protocol. #### **4. Transparency** <a href="#transparency" id="transparency"></a> * All major protocol decisions are made by the community of token holders, ensuring that the platform evolves in a way that benefits its users, not a central authority. * Projects are held accountable through standardized frameworks passed as governance proposals. Funding can be tied to the successful completion of verifiable milestones, aligning incentives with real-world progress. * Key metrics related to funding, expenditures, and performance are recorded on-chain, providing a clear and immutable record that is accessible to everyone. #### **5. Support** <a href="#support" id="support"></a> * The protocol provides access to shared tooling and automation, including BioAgents that can perform data analysis, generate hypotheses, and streamline operations, reducing costs and accelerating development for all projects. * Projects can unlock additional `bio/acc` rewards in the form of BIO tokens for hitting critical R\&D milestones, creating a powerful incentive to deliver on scientific outcomes. * The protocol helps projects maintain momentum through a regular cadence of updates, which are then amplified by a large, engaged community of researchers, investors, and enthusiasts. ### **Benefits for Researchers** <a href="#benefits-for-researchers" id="benefits-for-researchers"></a> * **Continuous, Rapid Research Funding** – Projects can secure funding quickly through transparent fixed-price sales. Hig
프로젝트로 돌아가기